Company Name Gemphire Therapeutics
Mailing Address 43334 Seven Mile Road Northville, MI 48167 USA
Company Description Our mission is to develop novel drugs, such as gemcabene, to treat the large, growing unmet need of dyslipidemia patients who are unable to reach optimal LDL cholesterol or triglyceride levels with statin or other therapies.
Proceeds Purposes Proceeds purposes were not disclosed. 59 investors participated in the offering as amended. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.